Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ali Pourmand and Omar Belfaqeeh.
Ali Pourmand
Connection Strength
3.025
Omar Belfaqeeh
  1. Therapeutic anticoagulation in COVID-19 patients. Thromb Res. 2021 12; 208:213.
    View in: PubMed
    Score: 0.930
  2. Azithromycin, a questionable treatment for COVID-19. Int J Antimicrob Agents. 2021 Mar; 57(3):106280.
    View in: PubMed
    Score: 0.925
  3. Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting. Int Immunopharmacol. 2021 12; 101(Pt B):107878.
    View in: PubMed
    Score: 0.238
  4. Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study. Infect Dis Ther. 2021 Sep; 10(3):1807-1809.
    View in: PubMed
    Score: 0.236
  5. COVID-19: could CT provide the best population level biomarker? Incidental COVID-19 in major trauma patients suggests higher than predicted rates of infection in London. Clin Radiol. 2021 06; 76(6):467.
    View in: PubMed
    Score: 0.234
  6. Organizational characteristics: Effect on outcome of ICU COVID-19 patients in Belgium. Lancet Reg Health Eur. 2021 Apr; 3:100062.
    View in: PubMed
    Score: 0.234
  7. Novaferon, treatment in COVID-19 patients. Int J Infect Dis. 2021 02; 103:297.
    View in: PubMed
    Score: 0.229
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.